DONENBERG PHILIP B
Insider CIK 1238120 · DEPO SVP and CFO · BPAX Sr VP of Finance, CFO, Secy · RESX Chief Financial Officer, Director · AVXS Chief Financial Officer · AVRO Director · TSHA Director · SNSE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics, In | A Award deriv | 2026-06-10 | 2026-06-12 | 12,500 | — | $0 | 12,500 | SEC↗ |
| TECX Tectonic Therapeutic, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 10,200 | — | $0 | 10,200 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2026-06-01 | 2026-06-02 | 42,671 | — | $0 | 42,671 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2026-06-01 | 2026-06-02 | 21,335 | — | $0 | 241,289 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award deriv | 2026-04-10 | 2026-04-14 | 23,100 | — | $0 | 23,100 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award deriv | 2026-02-13 | 2026-02-17 | 1,900 | — | $0 | 1,900 | SEC↗ |
| TECX Tectonic Therapeutic, Inc. | A Award deriv | 2025-06-09 | 2025-06-11 | 10,200 | — | $0 | 10,200 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2025-06-02 | 2025-06-04 | 113,246 | — | $0 | 113,246 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2025-06-02 | 2025-06-04 | 56,623 | — | $0 | 219,954 | SEC↗ |
| TECX Tectonic Therapeutic, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 11,760 | — | $0 | 11,760 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2024-05-29 | 2024-05-31 | 98,440 | — | $0 | 98,440 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award | 2024-05-29 | 2024-05-31 | 49,220 | — | $0 | 163,331 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2023-08-16 | 2023-08-16 | 111,111 | $0.90 | $100.0K | 114,111 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2023-06-22 | 2023-06-26 | 36,200 | — | $0 | 36,200 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,643 | — | $0 | 17,643 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 15,500 | — | $0 | 15,500 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | P Buy | 2022-02-02 | 2022-02-03 | 3,000 | $7.78 | $23.3K | 3,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2021-06-17 | 2021-06-21 | 15,500 | — | $0 | 15,500 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 17,438 | — | $0 | 17,438 | SEC↗ |
| AVRO AVROBIO, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 2,000 | $11.71 | $23.4K | 2,000 | SEC↗ |
| TSHA Taysha Gene Therapies, Inc | A Award deriv | 2020-09-23 | 2020-09-25 | 31,000 | — | $0 | 31,000 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 9,675 | — | $0 | 9,675 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2018-07-16 | 2018-07-16 | 87,163 | — | $0 | 87,163 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2018-06-20 | 2018-06-22 | 18,743 | — | $0 | 18,743 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 10,000 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 4,406 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 5,594 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 15,000 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 20,000 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 3,800 | — | $0 | 3,800 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2018-03-13 | 2018-03-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award | 2018-03-13 | 2018-03-27 | 3,800 | — | $0 | 3,800 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2017-10-19 | 2017-10-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RESX RestorGenex Corp | A Award deriv | 2014-07-24 | 2014-07-29 | 271,475 | — | $0 | 271,475 | SEC↗ |
| RESX RestorGenex Corp | A Award deriv | 2014-05-27 | 2014-06-06 | 250,000 | — | $0 | 250,000 | SEC↗ |
| BPAX BIOSANTE PHARMACEUTICALS I | A Award deriv | 2012-01-25 | 2012-01-27 | 285,000 | — | $0 | 285,000 | SEC↗ |